CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $239,000 | +0.8% | 295,067 | -0.7% | 0.00% | – |
| Q4 2021 | $237,000 | -33.2% | 297,244 | -0.4% | 0.00% | – |
| Q3 2021 | $355,000 | -5.8% | 298,442 | +22.7% | 0.00% | – |
| Q2 2021 | $377,000 | -80.9% | 243,200 | -70.4% | 0.00% | – |
| Q1 2021 | $1,970,000 | -29.0% | 820,622 | -12.7% | 0.00% | -100.0% |
| Q4 2020 | $2,773,000 | +100.2% | 940,103 | +3.8% | 0.00% | – |
| Q3 2020 | $1,385,000 | -28.6% | 905,326 | +16.6% | 0.00% | – |
| Q2 2020 | $1,941,000 | +59.0% | 776,124 | +29.6% | 0.00% | – |
| Q1 2020 | $1,221,000 | -30.6% | 598,766 | +5.1% | 0.00% | – |
| Q4 2019 | $1,760,000 | -13.7% | 569,671 | -6.7% | 0.00% | – |
| Q3 2019 | $2,040,000 | +5.0% | 610,524 | +0.6% | 0.00% | – |
| Q2 2019 | $1,942,000 | +12.7% | 606,766 | +1.0% | 0.00% | – |
| Q1 2019 | $1,723,000 | -28.6% | 600,509 | +0.1% | 0.00% | -100.0% |
| Q4 2018 | $2,412,000 | -16.2% | 600,051 | -2.7% | 0.00% | 0.0% |
| Q3 2018 | $2,880,000 | -38.1% | 616,744 | +9.1% | 0.00% | 0.0% |
| Q2 2018 | $4,654,000 | +1411.0% | 565,458 | +664.3% | 0.00% | – |
| Q1 2018 | $308,000 | +28.3% | 73,987 | 0.0% | 0.00% | – |
| Q4 2017 | $240,000 | +336.4% | 73,987 | +138.4% | 0.00% | – |
| Q3 2017 | $55,000 | +71.9% | 31,034 | 0.0% | 0.00% | – |
| Q2 2017 | $32,000 | -27.3% | 31,034 | 0.0% | 0.00% | – |
| Q1 2017 | $44,000 | +131.6% | 31,034 | +79.7% | 0.00% | – |
| Q4 2016 | $19,000 | 0.0% | 17,273 | +1.2% | 0.00% | – |
| Q3 2016 | $19,000 | -5.0% | 17,075 | 0.0% | 0.00% | – |
| Q2 2016 | $20,000 | +11.1% | 17,075 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | +12.5% | 17,075 | 0.0% | 0.00% | – |
| Q4 2015 | $16,000 | -11.1% | 17,075 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -41.9% | 17,075 | 0.0% | 0.00% | – |
| Q2 2015 | $31,000 | 0.0% | 17,075 | -18.9% | 0.00% | – |
| Q1 2015 | $31,000 | +6.9% | 21,042 | -0.7% | 0.00% | – |
| Q4 2014 | $29,000 | -23.7% | 21,183 | 0.0% | 0.00% | – |
| Q3 2014 | $38,000 | – | 21,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |